54.64
price down icon0.44%   -0.24
pre-market  プレマーケット:  54.76   0.12   +0.22%
loading
前日終値:
$54.88
開ける:
$55
24時間の取引高:
2.66M
Relative Volume:
1.15
時価総額:
$8.57B
収益:
$1.17B
当期純損益:
$150.71M
株価収益率:
58.13
EPS:
0.94
ネットキャッシュフロー:
$245.03M
1週間 パフォーマンス:
-5.58%
1か月 パフォーマンス:
+2.82%
6か月 パフォーマンス:
-27.39%
1年 パフォーマンス:
-29.64%
1日の値動き範囲:
Value
$53.96
$55.23
1週間の範囲:
Value
$52.99
$58.50
52週間の値動き範囲:
Value
$46.01
$80.95

Bio Techne Corp Stock (TECH) Company Profile

Name
名前
Bio Techne Corp
Name
セクター
Healthcare (1162)
Name
電話
(612) 379-8854
Name
住所
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
職員
3,100
Name
Twitter
@biotechne
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
TECH's Discussions on Twitter

TECH を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TECH
Bio Techne Corp
54.64 8.60B 1.17B 150.71M 245.03M 0.94
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
374.98 121.28B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
569.90 60.58B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
418.91 54.99B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
674.90 42.25B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.23 32.93B 3.81B -644.79M -669.77M -6.24

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-22 再開されました Stephens Overweight
2025-07-09 開始されました TD Cowen Buy
2025-05-30 開始されました Wells Fargo Overweight
2025-04-09 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 開始されました Evercore ISI Outperform
2025-02-19 ダウングレード Robert W. Baird Outperform → Neutral
2024-05-22 ダウングレード Citigroup Buy → Neutral
2024-02-08 開始されました Scotiabank Sector Outperform
2024-02-02 ダウングレード Stifel Buy → Hold
2023-12-07 開始されました UBS Buy
2023-08-28 開始されました William Blair Outperform
2023-01-10 アップグレード Wells Fargo Underweight → Equal Weight
2022-12-14 開始されました Deutsche Bank Buy
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-12-07 開始されました RBC Capital Mkts Sector Perform
2022-08-25 開始されました Credit Suisse Outperform
2022-04-25 ダウングレード Wells Fargo Equal Weight → Underweight
2021-09-15 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 アップグレード Stephens Equal-Weight → Overweight
2021-02-23 アップグレード Stifel Hold → Buy
2021-01-25 繰り返されました The Benchmark Company Buy
2020-11-10 開始されました KeyBanc Capital Markets Sector Weight
2020-09-30 開始されました Atlantic Equities Overweight
2020-07-15 ダウングレード Stephens Overweight → Equal-Weight
2020-05-27 ダウングレード Stifel Buy → Hold
2020-05-14 開始されました The Benchmark Company Buy
2020-01-08 再開されました Stephens Overweight
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-11-15 開始されました Stifel Buy
2019-07-02 アップグレード Janney Neutral → Buy
2019-01-14 アップグレード Stephens Equal-Weight → Overweight
2018-10-31 ダウングレード Craig Hallum Buy → Hold
2018-10-17 開始されました Goldman Neutral
2018-06-15 開始されました Argus Buy
2017-07-13 開始されました Wells Fargo Market Perform
2017-02-09 開始されました Citigroup Buy
2017-01-18 開始されました Deutsche Bank Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-01-21 繰り返されました Robert W. Baird Outperform
2013-09-20 アップグレード Robert W. Baird Neutral → Outperform
すべてを表示

Bio Techne Corp (TECH) 最新ニュース

pulisher
08:01 AM

Bio-Techne Exceeds Forecasts And Refines Its Focus On Growth - Finimize

08:01 AM
pulisher
06:48 AM

Bio-Techne earnings beat by $0.03, revenue topped estimates - Investing.com Canada

06:48 AM
pulisher
06:38 AM

Bio-techne declares quarterly dividend of $0.08 per share - Investing.com

06:38 AM
pulisher
06:32 AM

Bio-Techne Earnings Beat Estimates as Cell Therapy Division Drives Growth, Strategic Divestiture Announced - Stock Titan

06:32 AM
pulisher
06:30 AM

Dividend Alert: Bio-Techne Sets $0.08 Per Share Payout, Reveals August Payment Timeline - Stock Titan

06:30 AM
pulisher
Aug 05, 2025

Bio-techne to sell exosome diagnostics business to mdxhealth By Investing.com - Investing.com South Africa

Aug 05, 2025
pulisher
Aug 05, 2025

Bio-techne to sell exosome diagnostics business to mdxhealth - Investing.com

Aug 05, 2025
pulisher
Aug 05, 2025

Bio-Techne Sells Prostate Cancer Test Business to Strengthen Core Operations: Strategic Shift Revealed - Stock Titan

Aug 05, 2025
pulisher
Aug 05, 2025

Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne - The Manila Times

Aug 05, 2025
pulisher
Aug 05, 2025

Bio-Techne Q4 Earnings Preview: What's in Store for the Stock? - MSN

Aug 05, 2025
pulisher
Aug 05, 2025

Stock Analysis | Bio-Techne OutlookWeak Technicals but Strong Fundamentals - AInvest

Aug 05, 2025
pulisher
Aug 04, 2025

Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow - ca.finance.yahoo.com

Aug 04, 2025
pulisher
Aug 03, 2025

Why is Bio Techne Corporation stock attracting strong analyst attentionStay informed with daily expert analysis - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What drives Bio Techne Corporation stock priceExponential wealth increase - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

When is Bio Techne Corporation stock expected to show significant growthGain insights from top financial experts - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Is Bio Techne Corporation stock overvalued or undervaluedMassive profits - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

How strong is Bio Techne Corporation company’s balance sheetMaximize your returns with portfolio optimization - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

Bio Techne Corporation Shows Risk Reward Favoring UpsideAccurate Buy Point for Momentum Stocks Detected - beatles.ru

Aug 02, 2025
pulisher
Aug 01, 2025

Is it the right time to buy Bio Techne Corporation stockAI Powered Growth Plan For 2025 - Jammu Links News

Aug 01, 2025
pulisher
Aug 01, 2025

Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending - ca.finance.yahoo.com

Aug 01, 2025
pulisher
Aug 01, 2025

Bio-Techne Corporation (TECH) Slid on Rise in Investors’ Concerns - ca.finance.yahoo.com

Aug 01, 2025
pulisher
Jul 30, 2025

Promising Long-Term Growth for Bio-Techne Amidst Current Challenges: A Buy Recommendation by Kyle Boucher - TipRanks

Jul 30, 2025
pulisher
Jul 29, 2025

Will Bio Techne Corporation stock benefit from interest rate changesLow Risk High Return Opportunities Identified - beatles.ru

Jul 29, 2025
pulisher
Jul 28, 2025

Momentum Screeners Rank Bio Techne Corporation in Top 5 TodayReal-Time Trade Insights Spark Market Reactions - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

Why Bio Techne Corporation is moving today Weekly Setup Summary for Risk Controlled Trades - metal.it

Jul 28, 2025
pulisher
Jul 28, 2025

How many analysts rate Bio Techne Corporation as a “Buy”Discover the fastest growing stocks today - Jammu Links News

Jul 28, 2025
pulisher
Jul 28, 2025

Bio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen - Insider Monkey

Jul 28, 2025
pulisher
Jul 28, 2025

What makes Bio Techne Corporation stock price move sharplyAchieve rapid capital gains with smart investing - Jammu Links News

Jul 28, 2025
pulisher
Jul 27, 2025

Estimating The Intrinsic Value Of Bio-Techne Corporation (NASDAQ:TECH) - Yahoo Finance

Jul 27, 2025
pulisher
Jul 26, 2025

Bio-Techne’s Quarterly Earnings Preview: What You Need to Know - MSN

Jul 26, 2025
pulisher
Jul 25, 2025

10 Most Profitable Biotech Stocks to Invest in Now - Insider Monkey

Jul 25, 2025
pulisher
Jul 24, 2025

Bio-Techne Corporation (TECH): A Bull Case Theory - Yahoo Finance

Jul 24, 2025
pulisher
Jul 22, 2025

What analysts say about Bio Techne Corporation stockTriple returns potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Bio-Techne (TECH) Stock Is Up, What You Need To Know - Yahoo Finance

Jul 22, 2025
pulisher
Jul 22, 2025

Bio Techne Corporation Stock Analysis and ForecastFree Investment Community - Autocar Professional

Jul 22, 2025
pulisher
Jul 21, 2025

Bio-Techne Corporation shares rise 1.99% after-hours as US stocks close higher. - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch

Jul 21, 2025
pulisher
Jul 18, 2025

Envestnet Asset Management Inc. Sells 66,478 Shares of Bio-Techne Corp (NASDAQ:TECH) - Defense World

Jul 18, 2025
pulisher
Jul 18, 2025

Bio-Techne’s Quarterly Earnings Preview: What You Need To Know - Barchart.com

Jul 18, 2025
pulisher
Jul 17, 2025

Bio-Techne Schedules Q4 2025 Earnings Call: Full Fiscal Year Results Coming August 6 - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

Bio-Techne to distribute Spear Bio’s ultrasensitive immunoassays - Yahoo Finance

Jul 16, 2025
pulisher
Jul 16, 2025

Bio-Techne Corp (NASDAQ:TECH) Stake Lessened by M&T Bank Corp - Defense World

Jul 16, 2025
pulisher
Jul 16, 2025

Analysts Set Bio-Techne Corp (NASDAQ:TECH) Price Target at $70.00 - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

Why Bio Techne Corporation stock attracts strong analyst attentionProfitable Yet Secure Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Bio Techne Corporation stock performs during market volatilityFree Expert-Led Investment Training - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Here’s Headwaters Capital Management’s Investment Thesis for Bio-Techne (TECH) - Yahoo Finance

Jul 15, 2025
pulisher
Jul 15, 2025

Spear Bio partners with Bio-Techne to expand ultrasensitive assay access By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Spear Bio partners with Bio-Techne to expand ultrasensitive assay access - Investing.com

Jul 15, 2025
pulisher
Jul 15, 2025

Bio-Techne Secures 1000x More Sensitive Biomarker Detection Technology in Major Neuroscience Partnership - Stock Titan

Jul 15, 2025
pulisher
Jul 15, 2025

Bio-Techne (TECH) Partners with Spear Bio for Advanced Biomarker Detection | TECH Stock News - GuruFocus

Jul 15, 2025
pulisher
Jul 15, 2025

Revolutionary Alzheimer's Biomarker Detection: Bio-Techne's New Platform Achieves 1000x Higher Sensitivity - Stock Titan

Jul 15, 2025

Bio Techne Corp (TECH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Bio Techne Corp (TECH) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Kelderman Kim
Chief Executive Officer
Jul 22 '25
Option Exercise
44.33
48,176
2,135,642
90,379
Kelderman Kim
Chief Executive Officer
Jul 15 '25
Option Exercise
44.33
36,132
1,601,732
75,136
Herr Amy E.
Director
Jun 09 '25
Option Exercise
44.33
1,280
56,742
3,256
Herr Amy E.
Director
Jun 09 '25
Sale
49.77
1,280
63,705
1,976
$77.72
price down icon 0.40%
$37.91
price up icon 0.08%
$111.61
price up icon 0.33%
$29.13
price down icon 0.65%
$111.07
price up icon 0.95%
biotechnology ONC
$307.23
price up icon 0.96%
大文字化:     |  ボリューム (24 時間):